Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

FIP1L1-PDGFRalpha Positive Hypereosinophilic Syndrome (HES). The Response to Imatinib (IM) Is Durable. A Report of 21 Patients with a Follow-Up of 12 to 67 Months.

Michela Rondoni, Emanuela Ottaviani, Pier Paolo Piccaluga, Stefania Paolini, Serena Merante, Daniela Cilloni, Michele Malagola, Michela Palmisano, Tiziana Grafone, Francesca Messa, Francesco Buccisano, Mario Tiribelli, Fabrizio Pane, Giuseppe Saglio, Giovanni Martinelli, Michele Baccarani

Blood (2006) 108 (11): 2700.

https://doi.org/10.1182/blood.V108.11.2700.2700

Published: 2006

Journal Articles

FLT-3 Activity and Its Response to Drugs Can Be Determined in AML Blast Cells by FLT-3 Phosphorylation Status Using Flow Cytometry.

Tiziana Grafone, Michela Palmisano, Emanuela Ottaviani, Alberto Maria Martelli, Alessandra Cappellini, Matilde Follo, Nicoletta Testoni, Stefania Paolini, Michele Baccarani, Giovanni Martinelli

Blood (2006) 108 (11): 2308.

https://doi.org/10.1182/blood.V108.11.2308.2308

Published: 2006

Journal Articles

NPM Mutations and Not FLT3 Mutations Are a Potential Marker for Monitoring Minimal Residual Disease in Acute Myeloid Leukemia.

Michela Palmisano, Tiziana Grafone, Emanuela Ottaviani, Nicoletta Testoni, Stefania Paolini, Cristina Papayannidis, Michela Rondoni, Michele Baccarani, Giovanni Martinelli

Blood (2006) 108 (11): 2016.

https://doi.org/10.1182/blood.V108.11.2016.2016

Published: 2006

Journal Articles

Prevalence and Prognostic Significance of FLT3 Mutations in Acute Myeloid Leukemia: Association of ITDs with Poor Outcome in Patients with Normal Cytogenetics.

Michela Palmisano, Emanuela Ottaviani, Tiziana Grafone, Nicoletta Testoni, Stefania Paolini, Michela Rondoni, Michele Baccarani, Giovanni Martinelli

Blood (2006) 108 (11): 2017.

https://doi.org/10.1182/blood.V108.11.2017.2017

Published: 2006

Journal Articles

SU11657, a FLT3-Targeted Tyrosine Kinase, Has Pro-Apoptotic Activity on Leukemia Cells In Vitro.

Tiziana Grafone, Laura Ferraretti, Emanuela Ottaviani, Manuela Mancini, Michela Palmisano, Michele Malagola, Carolina Terragna, Matteo Renzulli, Angela Poerio, Marilina Amabile, Simona Soverini, Sabrina Colarossi, Ilaria Iacobucci, Michele Baccarani, Giovanni Martinelli

Blood (2005) 106 (11): 2797.

https://doi.org/10.1182/blood.V106.11.2797.2797

Published: 2005

NARROW

FIP1L1-PDGFRalpha Positive Hypereosinophilic Syndrome (HES). The Response to Imatinib (IM) Is Durable. A Report of 21 Patients with a Follow-Up of 12 to 67 Months.

FLT-3 Activity and Its Response to Drugs Can Be Determined in AML Blast Cells by FLT-3 Phosphorylation Status Using Flow Cytometry.

NPM Mutations and Not FLT3 Mutations Are a Potential Marker for Monitoring Minimal Residual Disease in Acute Myeloid Leukemia.

Prevalence and Prognostic Significance of FLT3 Mutations in Acute Myeloid Leukemia: Association of ITDs with Poor Outcome in Patients with Normal Cytogenetics.

SU11657, a FLT3-Targeted Tyrosine Kinase, Has Pro-Apoptotic Activity on Leukemia Cells In Vitro.

Email alerts

ASH Publications

American Society of Hematology

FIP1L1-PDGFRalpha Positive Hypereosinophilic Syndrome (HES). The Response to Imatinib (IM) Is Durable. A Report of 21 Patients with a Follow-Up of 12 to 67 Months.

FLT-3 Activity and Its Response to Drugs Can Be Determined in AML Blast Cells by FLT-3 Phosphorylation Status Using Flow Cytometry.

NPM Mutations and Not FLT3 Mutations Are a Potential Marker for Monitoring Minimal Residual Disease in Acute Myeloid Leukemia.

Prevalence and Prognostic Significance of FLT3 Mutations in Acute Myeloid Leukemia: Association of ITDs with Poor Outcome in Patients with Normal Cytogenetics.

SU11657, a FLT3-Targeted Tyrosine Kinase, Has Pro-Apoptotic Activity on Leukemia Cells In Vitro.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only